LEVETIRACETAM DEXCEL 1000

Riik: Iisrael

keel: inglise

Allikas: Ministry of Health

Osta kohe

Infovoldik Infovoldik (PIL)
22-11-2021
Avaliku hindamisaruande Avaliku hindamisaruande (PAR)
06-02-2020

Toimeaine:

LEVETIRACETAM

Saadav alates:

DEXCEL PHARMA TECHNOLOGIES LTD

ATC kood:

N03AX14

Ravimvorm:

TABLETS

Koostis:

LEVETIRACETAM 1000 MG

Manustamisviis:

PER OS

Retsepti tüüp:

Required

Valmistatud:

DEXCEL LTD, ISRAEL

Terapeutiline rühm:

LEVETIRACETAM

Terapeutiline ala:

LEVETIRACETAM

Näidustused:

Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

Loa andmise kuupäev:

2018-03-31

Dokumendid teistes keeltes

Infovoldik Infovoldik araabia 22-11-2021
Infovoldik Infovoldik heebrea 09-10-2023

Otsige selle tootega seotud teateid